Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Clinical trial NCT06475872 · COMPLETED

Trial details

NCT number: NCT06475872
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Hypercholesterolemia Combined Hyperlipidemia

Start date: 2023-11-20
Primary completion: 2023-12-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.